查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1780820

萤光导航手术系统的全球市场

Fluorescence Guided Surgery Systems
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 370 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年，全球萤光导航手术系统市场规模将达到 4.549 亿美元

全球萤光导航手术系统市场规模预计在2024年为2.086亿美元，到2030年将达到4.549亿美元，在2024-2030年的分析期内，复合年增长率为13.9%。 SPY系统是本报告分析的细分市场之一，预计其复合年增长率为13.0%，到分析期结束时将达到2.097亿美元。 PDE系统细分市场在分析期间内的复合年增长率预计为13.3%。

美国市场规模估计为 5,680 万美元，中国市场预计复合年增长率为 18.4%

预计2024年，美国萤光导航手术系统市场规模将达5,680万美元。作为世界第二大经济体的中国，预计到2030年市场规模将达到9,630万美元，在2024-2030年的分析期间内，复合年增长率为18.4%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为10.3%和12.3%。在欧洲，预计德国市场的复合年增长率为11.0%。

全球萤光导航手术系统市场－主要趋势与驱动因素摘要

为什么萤光导航手术正在改变肿瘤学和神经外科的格局

萤光导引导航手术(FGS) 透过使用萤光染料即时可视化肿瘤、淋巴结和关键组织，彻底改变了手术的精准度。该技术在肿瘤科、神经外科和微创手术中尤其重要，因为准确的肿瘤边缘检测对于完全切除至关重要。个人化癌症治疗的日益普及以及固体癌发生率的上升，推动了对 FGS 系统的需求。此外，近红外线(NIR) 影像和标靶萤光显影剂的进步正在提高手术精准度，降低復发率，并改善患者存活率。随着精准医疗的日益普及，萤光引导手术正成为复杂外科手术的标准。

哪些技术进步正在改善萤光导航手术系统？

分子影像、人工智慧驱动的萤光成像和生物相容性显影剂的突破正在增强FGS系统的有效性。选择性结合癌组织的靶向萤光探针的开发正在提高肿瘤的可见性并减少对健康结构的损害。人工智慧驱动的影像软体能够即时进行组织分化，从而更有效地指导外科医生进行手术。此外，将萤光与其他显像模式（例如MRI和PET扫描）相结合的混合成像系统正在提供多层次的洞察力，以便更好地做出手术决策。机器人辅助萤光引导手术的整合进一步提高了复杂手术的精确度并降低了其侵入性。

监管和市场趋势如何影响萤光导航手术？

美国食品药物管理局 (FDA) 和欧洲药品管理局 (EMA) 等监管机构监督萤光显影剂和影像系统的核准，确保其安全性和有效性。术中影像和精准肿瘤学日益受到重视，推动了萤光引导成像 (FGS) 在癌症治疗方案中的应用。此外，微创手术的需求也促使医院投资先进的萤光导引腹腔镜和机器人手术系统。人工智慧辅助手术计画工具的扩展也影响着市场成长，使其能够更好地进行术前肿瘤和血管结构的绘製。随着手术技术的进步，萤光导引手术正成为改善病患预后的重要工具。

什么将推动萤光导航手术系统市场的未来成长？

人工智慧影像分析、新一代萤光显影剂以及机器人辅助手术平台的日益普及，正在塑造FGS的未来。针对特定癌症的分子影像染料的开发将进一步提高肿瘤定位和手术精准度。人工智慧决策支援工具将增强即时术中引导，减少手术失误并提高切除完整性。此外，远距手术和远距机器人手术的不断扩展应用，将使FGS更容易在医疗资源匮乏的地区普及。随着精准手术需求的不断增长，萤光导航手术将继续重新定义现代肿瘤外科和神经外科。

部分

类型（SPY 系统、PDE 系统、VS3 铱系统、其他）、手术（开放性手术、腹腔镜/内视镜手术）、应用（癌症手术、心血管手术、其他）

受访公司范例

  • Accuray Incorporated
  • Arthrex, Inc.
  • Bracco Imaging SpA
  • Curadel LLC
  • Elekta AB
  • Fluoptics
  • Getinge AB
  • Hamamatsu Photonics KK
  • Intuitive Surgical, Inc.
  • Karl Kaps GmbH & Co. KG
  • Karl Storz SE & Co. KG
  • Leica Microsystems（Danaher Corporation）
  • LI-COR Biosciences
  • Lumicell Inc.
  • Medtronic plc
  • Mizuho Medical Co., Ltd.
  • MolecuLight Inc.
  • NICO Corporation
  • Novadaq Technologies Inc.（Stryker）
  • Olympus Corporation

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global 特定产业产业SLM 的典型规范，而是建立了一个从世界各地专家收集的内容库，包括影片录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP31004

Global Fluorescence Guided Surgery Systems Market to Reach US$454.9 Million by 2030

The global market for Fluorescence Guided Surgery Systems estimated at US$208.6 Million in the year 2024, is expected to reach US$454.9 Million by 2030, growing at a CAGR of 13.9% over the analysis period 2024-2030. SPY Systems, one of the segments analyzed in the report, is expected to record a 13.0% CAGR and reach US$209.7 Million by the end of the analysis period. Growth in the PDE Systems segment is estimated at 13.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$56.8 Million While China is Forecast to Grow at 18.4% CAGR

The Fluorescence Guided Surgery Systems market in the U.S. is estimated at US$56.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$96.3 Million by the year 2030 trailing a CAGR of 18.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 10.3% and 12.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 11.0% CAGR.

Global Fluorescence Guided Surgery Systems Market - Key Trends & Drivers Summarized

Why Is Fluorescence Guided Surgery Becoming a Game-Changer in Oncology and Neurosurgery?

Fluorescence guided surgery (FGS) is revolutionizing surgical precision by enabling real-time visualization of tumors, lymph nodes, and critical tissues using fluorescent dyes. This technique is particularly valuable in oncology, neurosurgery, and minimally invasive procedures, where precise tumor margin detection is essential for complete resection. The growing adoption of personalized cancer treatment and the increasing prevalence of solid tumors are driving demand for FGS systems. Additionally, advancements in near-infrared (NIR) imaging and targeted fluorescence contrast agents are enhancing surgical accuracy, reducing recurrence rates, and improving patient survival. As precision medicine gains traction, fluorescence guided surgery is becoming a standard in complex surgical interventions.

What Technological Advancements Are Improving Fluorescence Guided Surgery Systems?

Breakthroughs in molecular imaging, AI-powered fluorescence mapping, and biocompatible contrast agents are enhancing the efficacy of FGS systems. The development of targeted fluorescent probes that bind selectively to cancerous tissues is improving tumor visibility and reducing damage to healthy structures. AI-driven imaging software is enabling real-time tissue differentiation, guiding surgeons more effectively during procedures. Additionally, hybrid imaging systems combining fluorescence with other imaging modalities, such as MRI and PET scans, are providing multi-layered insights for better surgical decision-making. The integration of robotic-assisted fluorescence guided surgery is further enhancing precision and reducing invasiveness in complex operations.

How Are Regulations and Market Trends Influencing Fluorescence Guided Surgery?

Regulatory agencies such as the FDA and EMA oversee the approval of fluorescence contrast agents and imaging systems, ensuring their safety and effectiveness. The increasing emphasis on intraoperative imaging and precision oncology is driving the adoption of FGS in cancer treatment protocols. Additionally, the demand for minimally invasive procedures is encouraging hospitals to invest in advanced fluorescence-guided laparoscopic and robotic surgery systems. The expansion of AI-assisted surgical planning tools is also influencing market growth, enabling better preoperative mapping of tumors and vascular structures. As surgical technology evolves, fluorescence guided surgery is becoming an indispensable tool for improving patient outcomes.

What’s Driving the Future Growth of the Fluorescence Guided Surgery Systems Market?

The future of FGS is being shaped by AI-enhanced imaging analytics, next-generation fluorescent contrast agents, and the increasing adoption of robotic-assisted surgical platforms. The development of targeted molecular imaging dyes for specific cancers will further improve tumor localization and surgical precision. AI-powered decision support tools will enhance real-time intraoperative guidance, reducing surgical errors and improving resection completeness. Additionally, the expansion of tele-surgical and remote robotic surgery applications will make FGS more accessible in underserved regions. As demand for precision surgery grows, fluorescence guided surgery will continue to redefine modern surgical oncology and neurosurgery.

SCOPE OF STUDY:

The report analyzes the Fluorescence Guided Surgery Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (SPY Systems, PDE Systems, VS3 Iridium Systems, Other Types); Surgery (Open Surgery, Laparoscopy / Endoscopy Surgery); Application (Cancer Surgery Application, Cardiovascular Surgery Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 37 Featured) -

  • Accuray Incorporated
  • Arthrex, Inc.
  • Bracco Imaging S.p.A.
  • Curadel LLC
  • Elekta AB
  • Fluoptics
  • Getinge AB
  • Hamamatsu Photonics K.K.
  • Intuitive Surgical, Inc.
  • Karl Kaps GmbH & Co. KG
  • Karl Storz SE & Co. KG
  • Leica Microsystems (Danaher Corporation)
  • LI-COR Biosciences
  • Lumicell Inc.
  • Medtronic plc
  • Mizuho Medical Co., Ltd.
  • MolecuLight Inc.
  • NICO Corporation
  • Novadaq Technologies Inc. (Stryker)
  • Olympus Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Fluorescence Guided Surgery Systems - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Preference for Precision-Guided Oncologic Surgeries Propels Market Growth
    • Advancements in Near-Infrared and Multispectral Imaging Improve Visualization Accuracy
    • Increasing FDA and CE Approvals for Targeted Imaging Agents Expand Clinical Use
    • Growing Application in Neurosurgery, Urology, and Reconstructive Surgery Broadens Scope
    • Integration With Robotic Surgery Platforms Enhances Surgical Workflow Synergies
    • Development of Target-Specific Fluorescent Dyes Improves Tumor Margin Identification
    • Growth in Minimally Invasive Surgery Drives Demand for Real-Time Visualization Tools
    • AI-Based Image Enhancement Technologies Enable Faster, More Accurate Interpretation
    • Hospital Investments in Hybrid Operating Rooms Support System Installations
    • Surgeon Training and Awareness Campaigns Boost Institutional Adoption Rates
    • Demand for Organ-Sparing Surgical Techniques Encourages Use in High-Precision Interventions
    • Strategic Collaborations Between Imaging System Manufacturers and Pharma Firms Accelerate Innovation
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Fluorescence Guided Surgery Systems Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Fluorescence Guided Surgery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Fluorescence Guided Surgery Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for SPY Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for SPY Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for SPY Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for PDE Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for PDE Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for PDE Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for VS3 Iridium Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for VS3 Iridium Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for VS3 Iridium Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Open Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Open Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Open Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Laparoscopy / Endoscopy Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Laparoscopy / Endoscopy Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Laparoscopy / Endoscopy Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Cancer Surgery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Cancer Surgery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Cancer Surgery Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Cardiovascular Surgery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Cardiovascular Surgery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Cardiovascular Surgery Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Fluorescence Guided Surgery Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Fluorescence Guided Surgery Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 107: UK Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 118: Spain 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 127: Russia 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Fluorescence Guided Surgery Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Fluorescence Guided Surgery Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 157: Australia 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • INDIA
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 164: India Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 166: India 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 175: South Korea 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Fluorescence Guided Surgery Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 193: Latin America 15-Year Perspective for Fluorescence Guided Surgery Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 205: Argentina 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 214: Brazil 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 223: Mexico 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 232: Rest of Latin America 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Fluorescence Guided Surgery Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 241: Middle East 15-Year Perspective for Fluorescence Guided Surgery Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 253: Iran 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 262: Israel 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 271: Saudi Arabia 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 280: UAE 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 289: Rest of Middle East 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • AFRICA
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 298: Africa 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION